Skip to content

Development of an Integrated Positron Emission Tomography/Magnetic Resonance (PET/MR) System, Accessories and Components

Development of an Integrated PET/MR System, Accessories and Components

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01992354
Enrollment
4
Registered
2013-11-25
Start date
2013-11-30
Completion date
2015-01-31
Last updated
2019-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Indication for a PET CT Exam

Brief summary

The PET/MR device components and accessories are under development in order to optimize, validate and improve the design including improving the quality of images. The purpose of this study is: * Aim 1: Perform iterative evaluations of the device (including features and components) to optimize device performance and assess feasibility of new features; * Aim 2: Perform activities in support of design validation as needed for regulatory submission; * Aim 3: Evaluate device complaints and analyze potential causes.

Detailed description

This is a non-randomized, non-statistically powered, single-site, prospective study designed to gather imaging data for design optimization, regulatory submission and future product development of an investigational hybrid PET/MRI scanner. Subjects will undergo a clinically indicated PET/CT exam subsequent to tracer administration. Once clinical imaging is complete, subjects will be transported to the PET/MR scanner at the General Electric (GE) Facility for additional imaging. No additional pharmaceuticals or ionizing radiation will be utilized as part of this study.

Interventions

DEVICEPET MR Device

GE PET/MRI system

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject must have a clinical indication for a PET/CT exam * Subject must be at least eighteen (18) years of age; and * Subject must be able to hear and understand instructions without assistive devices; and * Subjects must be ambulatory, and able to walk 350 feet without any assistive devices and climb 2 steps; and * Subject must be able to provide identification with photograph; and * Female subjects with negative urine pregnancy test performed within 24 hours prior to the clinical PET/CT imaging; and * Subject must provide written informed consent; and * Subject has the necessary mental capacity to understand instructions, and is able to comply with protocol requirements; and * Subject is able to remain still for duration of imaging procedure (approximately 60 minutes total for PET/MRI); and * Subject must be able to participate in a PET/MR imaging session within 1 hour of concluding their PET/CT exam

Exclusion criteria

* General Electric Healthcare (GEHC) employees; or * GEHC contractors; or * Healthcare providers (Any person in a position to purchase, lease, recommend, use, prescribe or arrange for the purchase or lease of any GEHC product or service that is reimbursable under any government program or private health insurance) or employees/contractors of medical device companies (as determined by self-report); or * Female subjects with known or suspected pregnancy; or * Subjects who have any axial diameter larger than 55 cm; or * Subjects with a weight greater than 227 kgs; or * Subjects who currently have, or have ever had a Cardiac Pacemaker or Defibrillator with implanted components; or * Subjects who are currently undergoing a gastrointestinal study involving swallowing of camera pill or similar device; or * Subjects who have any of the conditions below at the time of the scan session: * Prior negative experience or problem related to a previous MRI examination * Eye injury involving a metallic object * Potential for metal to be in body due to a previous injury involving metallic objects * Taking fertility medication or having fertility treatment * Cochlear, otologic or other ear implant * Insulin or other infusion pump * Implanted drug infusion device * Any type of prosthesis (eye, penile, etc) * Swan-Ganz or thermodilution catheter * Any metallic fragment or foreign body * Artificial or prosthetic limb * Bone/joint pin, screw, nail, wire, plate, etc * Neurostimulation system * Surgical staples, clips, or metallic sutures; * Implanted cardioverter defibrillator (ICD); * Magnetically activated implant or device; * Vascular access port and/or catheter; * Medication patch (Nicotine, Nitroglycerine); * Internal electrodes or wires; * External electronic medical device * Bone growth/bone fusion stimulator * Radiation seeds or implants * Heart valve prosthesis * Spinal cord stimulator * Eyelid spring or wire * Wire mesh implant * Tissue expander (e.g. breast) * Aneurysm clip(s) * Joint replacement (hip, knee, etc…) * Vascular or other stent(s), filter(s) or coil(s) * Intra-uterine device, diaphragm or pessary * Shunt (spinal or intraventricular) * Loose dental fillings * Dental fillings or crowns placed in the past 30 days * Tattoo or permanent makeup * Any implant * Breathing problem or motion disorder * Claustrophobia or panic attacks * Hearing Aid * Body piercing jewelry * Dentures or partial plates * External medical hardware (e.g. orthopedic braces) * Orthodontic appliances (e.g. braces, expanders) * Known or past allergic reactions to latex

Design outcomes

Primary

MeasureTime frameDescription
PET/MR Scan ObtainedOne (1) dayOne PET/MR scan per subject should be obtained. The scan images are evaluated by a subject matter expert for adequate diagnostic quality.

Secondary

MeasureTime frameDescription
Device ComplaintsOne dayNumber of device complaints reported during a scan

Countries

United States

Participant flow

Participants by arm

ArmCount
Single Arm
Evaluation of PET MR device for image assessment and device performance PET MR Device: GE PET/MRI system
4
Total4

Baseline characteristics

CharacteristicSingle Arm
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
4 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
4 participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 4
other
Total, other adverse events
0 / 4
serious
Total, serious adverse events
0 / 4

Outcome results

Primary

PET/MR Scan Obtained

One PET/MR scan per subject should be obtained. The scan images are evaluated by a subject matter expert for adequate diagnostic quality.

Time frame: One (1) day

ArmMeasureGroupValue (NUMBER)
PET/MR SystemPET/MR Scan ObtainedScans supporting Aim 15 scans completed
PET/MR SystemPET/MR Scan ObtainedScans supporting Aim 20 scans completed
PET/MR SystemPET/MR Scan ObtainedScans supporting Aim 30 scans completed
Secondary

Device Complaints

Number of device complaints reported during a scan

Time frame: One day

ArmMeasureValue (NUMBER)
PET/MR SystemDevice Complaints0 Device complatints reported

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026